A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus

NCT03586830 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity and Diabetes Mellitus, Type 2

Interventions

DRUG: JNJ-64565111 Dose Level 1
DRUG: JNJ-64565111 Dose Level 2
DRUG: JNJ-64565111 Dose Level 3
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC